Neuroleptic malignant syndrome precipitated by promethazine and lorazepam.
Duggal
H S
HS
D000293:Adolescent; D000927:Anticonvulsants / Q000009:adverse effects*; D014150:Antipsychotic Agents / Q000009:adverse effects; D001480:Basal Ganglia Diseases / Q000188:drug therapy*; D006634:Histamine H1 Antagonists / Q000009:adverse effects*; D006801:Humans; D008140:Lorazepam / Q000009:adverse effects*; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D011398:Promethazine / Q000009:adverse effects*; D011595:Psychomotor Agitation / Q000188:drug therapy*; D013375:Substance Withdrawal Syndrome / Q000209:etiology
D000927:Anticonvulsants; D014150:Antipsychotic Agents; D006634:Histamine H1 Antagonists; D011398:Promethazine; D008140:Lorazepam